Trials / Completed
CompletedNCT04905654
Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the migraine inducing effect of levcromakalim in patients with migraine with aura.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levcromakalim | To investigate the role of levcromakalim compared with placebo in migraine with aura patients |
| DRUG | Saline | To investigate the role of levcromakalim compared with placebo in migraine with aura patients |
Timeline
- Start date
- 2021-09-29
- Primary completion
- 2023-05-16
- Completion
- 2023-05-16
- First posted
- 2021-05-27
- Last updated
- 2023-05-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04905654. Inclusion in this directory is not an endorsement.